PharmaKinnex

AUGUST 23, 2022

More convenience and safety? Bearing the brunt of these COVID19 restrictions, pharmaceutical reps have had a hard time getting in the door to make sales, and their employers have noticed: Limited In-Person Access To HCPs. Fewer Networking & Industry Trade Show Events. What’s not to love? Higher Travel & Marketing Costs.

Pharma 52

Pharma Sales Sales Strategy Marketing 52

European Pharmaceutical Review

SEPTEMBER 22, 2023

Targeting toxic species of Abeta, such as multimers (with aducanumab and lecanemab) or pyroglutamate Abeta3-42 (with donanemab), induced significant removal of Abeta plaque load in the brains of Alzheimer’s patients, leading to the delay in cognitive decline. Treatment with the mAbs delayed cognitive decline by 2.6 months for lecanemab and 5.5

Food and Drug Administration 75

Food and Drug Administration Safety Patients Leads 75

Pharma Marketing Network

MAY 3, 2023

This involves paying researchers and scientists to publish articles or conduct studies that support the use of a particular drug, while suppressing or ignoring research that casts doubt on the drug’s safety or efficacy. Pharmaceutical research and development: what do we get for all that money? References: 1.

Pharmaceutical 52

Pharmaceutical Medical Prescription Pharmaceutical research 52